Envoy Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Key Highlights
- ➤Envoy Medical (COCH) regained Nasdaq minimum bid compliance after 10 consecutive days above $1.00.
- ➤1-for-10 reverse split became effective October 26, 2026, restoring compliance.
- ➤Class A common stock will continue trading on Nasdaq Capital Market under COCH.
- ➤Company now meets all applicable continued listing standards.
White Bear Lake, Minnesota--(Newsfile Corp. - November 10, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(1), the minimum bid price requirement, as the closing bid price of the Company's Class A common stock was at or above $1.00 per share for 10 consecutive trading days.
As previously disclosed, the Company received a notice from Nasdaq on November 19, 2025, indicating that it was not in compliance with the minimum bid price requirement. Following the Company's 1-for-10 reverse stock split, which became effective on October 26, 2026, the closing bid price of the Company's Class A common stock was at or above $1.00 per share for 10 consecutive trading days, resulting in compliance with the rule.
Get started
Create a free account to read the full story.